Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10957252 | 0.83 | PPARA (0.52) | PPARAPPARGSELPALOX5PPARD | |
| SCHEMBL6943847 | 0.81 | PPARA (0.40) | PPARAPPARGPPARD | |
| SCHEMBL7415347 | 0.80 | PPARA (0.58) | PPARAPPARGSELPALOX5MAPT | |
| SCHEMBL9175204 | 0.80 | PPARA (0.58) | PPARAPPARGSELPALOX5POLB | |
| SCHEMBL7095615 | 0.79 | PPARA (0.59) | PPARAPPARGSELPALOX5POLB | |
| SCHEMBL6943609 | 0.78 | PPARA (0.56) | PPARAPPARGSELPALOX5POLB | |
| SCHEMBL4454899 | 0.77 | PPARA (0.58) | PPARAPPARGPPARD | |
| SCHEMBL9178152 | 0.77 | PPARA (0.51) | PPARAPPARGSELPALOX5MAPT | |
| SCHEMBL7410835 | 0.76 | GAA (0.65) | SELPALOX5 | |
| SCHEMBL12439701 | 0.76 | HPGD (0.61) | PPARAPPARGSELPALOX5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003103653-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES | ELAN PHARMACEUTICALS, INC. (US) | 2003-12-18 | — | — | WO | disclosed |